A significant predictor of in-hospital and long-term mortality and progression in COVID-19 patients: The end-stage liver disease (MELD) score model.

Kaya, Yasemin; Gülcü, Oktay; Aksakal, Emrah; Kalkan, Kamuran; Aydin, Sidar S; Kaya, Ahmet; Bostan, Sedat

Kaya, Yasemin; Gülcü, Oktay; Aksakal, Emrah; Kalkan, Kamuran; Aydin, Sidar S; Kaya, Ahmet; Bostan, Sedat.

Afiliação

Kaya Y; Department of Internal Medicine, Ordu University Medical Faculty, Ordu, Turkey.
Gülcü O; Erzurum Regional Training and Research Hospital, Erzurum, Turkey.
Aksakal E; Erzurum Regional Training and Research Hospital, Erzurum, Turkey.
Kalkan K; Erzurum Regional Training and Research Hospital, Erzurum, Turkey.
Aydin SS; Erzurum Regional Training and Research Hospital, Erzurum, Turkey.
Kaya A; Department of Cardiology, Ordu University Medical Faculty, Ordu, Turkey.
Bostan S; Health Care Management Department, Faculty of Health Science, Karadeniz Techinical University, Trabzon, Turkey.

J Med Virol ; 95(1): e28109, 2023 01.

Article em En | MEDLINE | ID: mdl-36043339

Assuntos

COVID-19; Doença Hepática Terminal; Humanos; Adulto; Pessoa de Meia-Idade; Doença Hepática Terminal/diagnóstico; Índice de Gravidade de Doença; Estudos Retrospectivos; Prognóstico; COVID-19/diagnóstico; COVID-19/complicações; Hospitais

Palavras-chave

COVID-19; in-hospital mortality; intensive care unit admission

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença Hepática Terminal / COVID-19 Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Humans / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google